Branched chain amino acids (BCAA) are a dietary supplement used to improve thinking during exercise. BCAA may improve your exercise and reduce your tiredness during exercise. BCAA may also be used to improve your diet. It may be used to treat loss of appetite and liver problems, such as cirrhosis (sir-O-sus). There have been many BCAA studies but the studies have not shown much benefit for its use.
Other names for BCAA include: BCAAs, Isoleucine, Leucine, L-Isoleucine, L-Leucine, L-Valine, and Valine.
Ask your doctor, nurse, or pharmacist if you need more information about this medicine or if any information in this leaflet concerns you.
Tell your doctor if you...
Talk with your caregiver about how much BCAA you should take. The amount depends on the strength of the medicine and the reason you are taking it. If you are using this medicine without instructions from your caregiver, follow the directions on the medicine bottle. Do not take more medicine or take it more often than the directions tell you to.
Keep all medicine locked up and away from children. Store medicine away from heat and direct light. Do not store your medicine in the bathroom, near the kitchen sink, or in other damp places. Heat or moisture may cause the medicine to break down and not work the way it should work. Throw away medicine that is out of date or that you do not need. Never share your medicine with others.
Stop taking your medicine right away and talk to your doctor if you have any of the following side effects. Your medicine may be causing these symptoms which may mean you are allergic to it.
You may have the following side effects, but this medicine may also cause other side effects. Tell your doctor if you have side effects that you think are caused by this medicine.
1. Product Information: FreAmine (R) HBC 6.9%. B Braun Medical, Inc, Irvine, CA (PI revised 02/1999) reviewed 03/2003.
2. Product Information: HepatAmine(R), branched chain amino acid mixture. Braun Medical Inc, Bethlehem, PA, 1999.
3. Akpolat T: Hyperammonemic encephalopathy due to intravenous essential amino acid administration in a patient with renal insufficiency. Nephron 1993; 63:239.
4. AMA Department of Drugs: AMA Drug Evaluations, 6th ed. American Medical Association, Chicago, IL, 1986.
5. Heird WMC, Nicholson JF, Driscoll JM Jr et al: Hypermonemia resulting from intravenous alimentation using synthetic 1-amino acids. J Pediatr 1972; 81:162-165.
6. Johnson JD, Albritton WL & Sunshine P: Hyperammonemia accompanying parenteral nutrition in newborn infants. J Pediatr 1972; 81:154-161.
7. Rodgers B, Hollenbeck JI, Donnelly WH et al: Intrahepatic cholestasis with parenteral alimentation. Am J Surg 1976; 131:149.